Delivery Order SPE2DB22D3016-SPE2DB25FBFH9
- Not listed
- The Defense Logistics Agency awarded a $10,223.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for LENVIMA 8 mg daily dose (60-count supply) with an ultimate completion date of September 2, 2025. This non-set-aside contract was competitively awarded on August 11, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. LENVIMA (lenvatinib) is a targeted cancer therapy used in the treatment of various malignancies, reflecting the...
- The Defense Logistics Agency awarded a $10,223.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for LENVIMA 10 mg daily dose tablets (30-count package) with an ultimate completion date of August 19, 2025. This non-competitive delivery order was issued without a set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. LENVIMA is a targeted cancer therapy indicated for multiple malignancies, and this award reflects...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for LENVIMA 18 mg daily dose tablets (90-count supply) valued at $10,223.24 under a firm fixed-price contract type. The award was made on August 8, 2025, with an ultimate completion date of August 29, 2025, and no set-aside designation was utilized. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this pharmaceutical delivery. This delivery order...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of LENVIMA 14 mg daily dose tablets (60-count packaging) with a contract ceiling value of $10,223.24. This competitive award, issued under a firm fixed price delivery order with no set-aside designation, is scheduled for ultimate completion on September 3, 2025, and will be performed at the contractor's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for LENVIMA 8 mg daily dose in a quantity of 60 units, with a ceiling value of $10,223.24. This firm fixed-price delivery order, issued on August 11, 2025, represents a non-competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of LENVIMA 10 MG DAILY DOSE 30S. The contract has a ceiling value of $9,910.95 and a period of performance ending on June 30, 2025. It is a firm-fixed-price delivery order contract, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $10,223.24 to AmerisourceBergen Drug Corp for the supply of Lenvima 8 mg daily dose in a quantity of 60 tablets. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 11, 2025, with performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was made without a set-aside designation, reflecting open competition among eligible vendors. This delivery...
- This is a $9,579.86 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of LENVIMA 14 MG DAILY DOSE 60S, a prescription medication. The award is part of a broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a comprehensive range of pharmaceutical and medical supplies...
- The Defense Logistics Agency's Medical Supply Chain awarded a $20.4K delivery order to AmerisourceBergen Drug Corp for the supply of LENVIMA 10 mg daily dose tablets (30-count packages) under a firm fixed price contract. The award, issued on August 4, 2025, with completion targeted for August 25, 2025, represents a non-competitive delivery order executed through the company's existing indefinite delivery contract (IDC) framework. Performance will be fulfilled from AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $10,223.24 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for Lenvima 8 mg daily dose tablets (60-count supply) with a completion deadline of August 20, 2025. This firm fixed price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award carries no set-aside designation, reflecting...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBFH9Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,223.24 to AmerisourceBergen Drug Corp for LENVIMA 10 MG daily dose tablets (30-count supply). This firm fixed-price, non-set-aside contract was awarded on August 18, 2025, with an ultimate completion date of September 9, 2025. LENVIMA (lenvatinib) is a targeted cancer therapy used to treat various malignancies, reflecting the pharmaceutical distributor's role in supplying specialized oncology medications to federal healthcare systems. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. This prime vendor contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide, including services to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The competitively awarded contract demonstrates AmerisourceBergen's capability to meet federal procurement requirements for critical specialty pharmaceuticals across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.2k | 8/18/25 |